Nancy S. Miller, MD

Associate Professor, Pathology & Laboratory Medicine

Nancy Miller
617.638.8705
1 Boston Medical Center Place – 670 Albany Street – Suite 733

Biography

Expertise includes: Clinical Microbiology & Infectious Diseases Diagnostics; Antimicrobial susceptibility testing; Special interest in translational research; New diagnostics for infectious diseases.

Other Positions

  • Chief and Vice Chair, Laboratory Medicine, Boston University School of Medicine
  • Medical Director, Clinical Microbiology & Molecular Diagnostics, Boston Medical Center
  • Chief and Vice Chair, Laboratory Medicine, Boston Medical Center

Education

  • Stony Brook University, MD
  • State University of New York at Binghamton, BA

Publications

  • Published on 5/1/2020

    Kim Vanuytsel, Aditya Mithal, Richard M. Giadone, Anthony K. Yeung, Taylor M. Matte, Todd W. Dowrey, Rhiannon B. Werder, Gregory J. Miller, Nancy S. Miller, Christopher D. Andry, George J. Murphy. Rapid Implementation of a SARS-CoV-2 Diagnostic qRT-PCR Test with Emergency Use Authorization at a Large Academic Safety-Net Hospital. Clinical and Translational Resource and Technology Insights. 2020.

    Read at: Custom
  • Published on 10/1/2019

    Emily R Jonica, MD, Carol A Sulis, MD, Kanupriya Soni, MD, Michelle Hughes, MD, Eric Jones, PhD, Janice Weinberg, ScD, Nancy S Miller, MD, Francis A Farraye, MD, MSc. Role of Cycle Threshold in Clostridioides difficile Polymerase Chain Reaction Testing as a Predictor of Clinical Outcomes in Patients with Inflammatory Bowel Disease. Crohn's & Colitis 360. 2019; 1(3).

    Read at: Custom
  • Published on 8/28/2019

    Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW. Correction for Kraft et al., "A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults". Clin Microbiol Rev. 2019 Sep 18; 32(4). PMID: 31462404.

    Read at: PubMed
  • Published on 7/10/2019

    Calner P, Sperring H, Ruiz-Mercado G, Miller NS, Andry C, Battisti L, Scrudder K, Shea F, Chan A, Schechter-Perkins EM. HCV screening, linkage to care, and treatment patterns at different sites across one academic medical center. PLoS One. 2019; 14(7):e0218388. PMID: 31291275.

    Read at: PubMed
  • Published on 5/29/2019

    Kraft CS, Parrott JS, Cornish NE, Rubinstein ML, Weissfeld AS, McNult P, Nachamkin I, Humphries RM, Kirn TJ, Dien Bard J, Lutgring JD, Gullett JC, Bittencourt CE, Benson S, Bobenchik AM, Sautter RL, Baselski V, Atlas MC, Marlowe EM, Miller NS, Fischer M, Richter SS, Gilligan P, Snyder JW. A Laboratory Medicine Best Practices Systematic Review and Meta-analysis of Nucleic Acid Amplification Tests (NAATs) and Algorithms Including NAATs for the Diagnosis of Clostridioides (Clostridium) difficile in Adults. Clin Microbiol Rev. 2019 06 19; 32(3). PMID: 31142497.

    Read at: PubMed
  • Published on 3/23/2019

    Madico G, Vinhas S, Orr B, White L, Gaeddert M, Miller NS, Mpeirwe M, Orikiriza P, Mwanga-Amumpaire J, Boum Y, Palaci M, Dietze R, Jones-López EC. Further evidence of Mycobacterium tuberculosis in the sputum of culture-negative pulmonary tuberculosis suspects using an ultrasensitive molecular assay. Tuberculosis (Edinb). 2019 05; 116:1-7. PMID: 30983569.

    Read at: PubMed
  • Published on 12/25/2018

    Oliva A, Giacobbe DR, Di Luca M, Miller NS. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic. Biomed Res Int. 2018; 2018:8905874. PMID: 30671476.

    Read at: PubMed
  • Published on 8/7/2018

    Schechter-Perkins EM, Mitchell PM, Nelson KP, Liu JH, Shannon A, Ahern J, Orr B, Miller NS. Point-of-care influenza testing does not significantly shorten time to disposition among patients with an influenza-like illness. Am J Emerg Med. 2019 05; 37(5):873-878. PMID: 30107967.

    Read at: PubMed
  • Published on 7/20/2018

    Schechter-Perkins EM, Miller NS, Hall J, Hartman JJ, Dorfman DH, Andry C, Linas BP. Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program. Acad Emerg Med. 2018 11; 25(11):1216-1226. PMID: 29851238.

    Read at: PubMed
  • Published on 5/6/2018

    Alekseyev YO, Fazeli R, Yang S, Basran R, Maher T, Miller NS, Remick D. A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? Acad Pathol. 2018 Jan-Dec; 5:2374289518766521. PMID: 29761157.

    Read at: PubMed

View 29 more publications: View full profile at BUMC

View all profiles